Background: An open-label extension study (NCT02873208) evaluated the long-term tolerability, safety, and efficacy of combination olanzapine/samidorphan (OLZ/SAM) treatment in patients wi...
Among patients with schizophrenia (SZ) and bipolar I disorder (BD-I) treated with second-generation antipsychotics (SGAs), clinically-significant weight gain (CSWG) and treatment interrup...
Background: Oral antipsychotic medications (OAMs) are frequently prescribed to patients with bipolar I disorder (BD-1) for symptom control. A cross-sectional survey examined side effects ...